# Ognomy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ognomy

- Industry: Healthcare IT
- Headquarters: Buffalo, US
- Website: www.ognomy.com
- Total disclosed funding: $16M
- Latest round: Series A (May 18, 2026)
- Investors on record: 6

## About

Founded in 2020 and based in New York, US, Ognomy Inc. operates as a provider of platforms for the diagnosis and treatment of sleep apnea. The company was co-founded by Daniel Rifkin (CEO). In May 2026, Ognomy, Inc. raised USD 14.9 million in series A funding led by Catalyst, with participation from Blue Heron Capital, Excell Partners, Launch NY, University at Buffalo Foundation - Endowment Portfolio, and Impellent Ventures.

Ognomy’s platform provides a solution for diagnosing and treating sleep apnea. It features virtual consultations with sleep medicine experts, home-based sleep testing, and a range of treatment options including CPAP therapy, oral appliances, implanted devices, and lifestyle changes. The service is designed to integrate seamlessly with various healthcare providers, including consumer health apps, dentists, and cardiologists.

The company will use the May 2026 funding to expand its sleep apnea care platform, add wearable device support, and grow its virtual care network.

## Funding rounds

- Series A, May 18, 2026, $15M — Catalyst, University at Buffalo Foundation INC, Blue Heron Capital, Excell Partners, Launch NY, Impellent Ventures
- Seed, Aug 6, 2024, $1.6M — Impellent Ventures

## Investors

- Impellent Ventures (https://capitalatlas.ai/funds/impellent-ventures) — Seed, Series A
- Catalyst (https://capitalatlas.ai/funds/catalyst) — Series A
- University at Buffalo Foundation INC — Series A
- Blue Heron Capital (https://capitalatlas.ai/funds/blue-heron-capital) — Series A
- Excell Partners (https://capitalatlas.ai/funds/excell-partners) — Series A
- Launch NY (https://capitalatlas.ai/funds/launch-ny) — Series A